Suxia Luo

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Jin Lü, Yuxian Bai, Teng Mao et al. · JAMA · 2021 · 801 citations · Full text

Medicine, Oncology, Pharmacology +17

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

Medicine, Oncology, Pharmacology +14

Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells

Xiaoli Liu, Qingfeng Jiang, Huaimin Liu et al. · Biological Research · 2019 · 130 citations · Full text

Medicine, Oncology, Pharmacology +14

FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway

Suxia Luo, Changgong Jin, Haiying Ma et al. · Cell Death and Disease · 2013 · 115 citations · Full text

Medicine, Oncology, Pharmacology +16

LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway

Xianfu Sun, Tao Huang, Zhenzhen Liu et al. · European Journal of Pharmacology · 2019 · 80 citations

Medicine, Molecular Biology, Molecular Genetics +17